Defendant Name:
Aegerion Pharmaceuticals, Inc.
Defendant Type:
Subsidiary of Public Company
Public Company Parent:
Novelion Therapeutics Inc.
SIC Code:
2834
CUSIP:
67001K20
Document Reference:
LR-23942
Document Details
Legal Case Name
SEC v. Aegerion Pharmaceuticals, Inc.
Document Name
Pharmaceutical Company Paying Penalty for Misleading Investors about Sales Metric
Document Date
22-Sep-2017
Document Format
Civil Proceeding
Case Number
17-cv-11817
Federal District Court
Massachusetts, District of Massachusetts
Allegation Type
Issuer Reporting and Disclosure
Document Summary
According to the SEC, Aegerion Pharmaceuticals, Inc. "exaggerated how many new patients actually filled prescriptions for an expensive drug that was its sole source of revenue."